|
0
|
|
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.
(nature.com)
|
Zhou H
…
Yang C
Nature Microbiology
2026-04-01
|
#microbiome
#metabolism
#metagenomics
#cancer
#immunotherapy
|
|
0
|
|
In vivo site-specific engineering to reprogram T cells.
(nature.com)
|
Nyberg WA
…
Eyquem J
Nature
2026-04-01
|
#cancer
#immunotherapy
#crispr
#gene therapy
#genome editing
|
|
0
|
|
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
(nature.com)
|
Porcari S
…
Ianiro G
Nature Medicine
2026-04-01
|
#microbiome
#dysbiosis
#cancer
#immunotherapy
#transplantation
|
|
0
|
|
High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sensitize cancer cells to targeted T cell cytotoxicity.
(nature.com)
|
Akana RV
…
Jerby L
Nature Genetics
2026-04-01
|
#transcriptomics
#cancer
#screening
#immunotherapy
#crispr
|
|
0
|
|
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.
(nature.com)
|
Mellema JJ
…
van der Heijden MS
Nature Medicine
2026-04-01
|
#clinical trial
#immunotherapy
#bladder cancer
#chemoradiotherapy
|
|
0
|
|
Pancreatic-targeted lipid nanoparticles based on organ capsule filtration.
(nature.com)
|
Lei J
…
Yu G
Nature
2026-04-01
|
#nanoparticles
#immunotherapy
#rna
#delivery
#pancreatic
|
|
0
|
|
Clinical progress of engineered cellular immunotherapies for autoimmunity.
(nature.com)
|
Solimani F
…
Payne AS
Nature Biotechnology
2026-04-01
|
#immunotherapy
#car-t
#regulatory t cells
#autoimmunity
#cellular engineering
|
|
0
|
|
Thymic health and immunotherapy outcomes in patients with cancer.
(nature.com)
|
Bernatz S
…
Aerts HJWL
Nature
2026-04-01
|
#immunity
#cancer
#immunotherapy
#biomarker
#t cell
|
|
0
|
|
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases.
(nature.com)
|
Dusing C
…
Distler JHW
Nature Medicine
2026-04-01
|
#immunotherapy
#autoimmune
#cytokine release syndrome
#t cell engager
|
|
0
|
|
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
(nature.com)
|
Wainberg ZA
…
O'Reilly EM
Nature Medicine
2026-04-01
|
#cancer
#clinical trial
#immunotherapy
#biomarker
#chemotherapy
|
|
0
|
|
The integrated stress response promotes immune evasion through lipocalin 2.
(nature.com)
|
Bossowski JP
…
Papagiannakopoulos T
Nature
2026-04-01
|
#metabolism
#immunosuppression
#immunity
#cancer
#immunotherapy
|
|
0
|
|
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.
(nature.com)
|
Li B
…
Veillette A
Nature
2026-04-01
|
#cancer
#immunotherapy
#t cell
#checkpoint
#exhaustion
|
|
0
|
|
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.
(nature.com)
|
Yang L
…
Chen S
Nature
2026-04-01
|
#cancer
#immunotherapy
#crispr
#engineering
#cytotoxicity
|
|
0
|
|
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
(nature.com)
|
Huang Z
…
Zhang Y
Nature Medicine
2026-04-01
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
#chronotherapy
|
|
0
|
|
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial.
(nature.com)
|
Fernandes R
…
Maleki Vareki S
Nature Medicine
2026-04-01
|
#microbiome
#immunity
#cancer
#immunotherapy
#transplantation
|
|
0
|
|
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.
(link.springer.com)
|
Priano I
…
Felip E
Genome Medicine
2026-04-01
|
#sequencing
#immunotherapy
#biomarker
#nsclc
#cnv
|
|
0
|
|
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
(nature.com)
|
Duttagupta S
…
Elkrief A
Nature Medicine
2026-04-01
|
#microbiome
#immunity
#metagenomics
#cancer
#immunotherapy
|
|
0
|
|
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study.
(nature.com)
|
An N
…
Li C
Nature Medicine
2026-04-01
|
#immunotherapy
#car-t
#multiple myeloma
#cytokine release syndrome
#lentiviral vector
|